Home > Boards > Canadian > Biotechs > Vanc Pharmaceuticals Inc. (TSXV:NPH)

Simple business model - Vanc sources drugs that

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
pointofreturn Member Profile
 
Followed By 20
Posts 585
Boards Moderated 0
Alias Born 01/21/11
160x600 placeholder
pointofreturn   Wednesday, 01/28/15 12:39:14 PM
Re: None
Post # of 4094 
Simple business model - Vanc sources drugs that have already obtained FDA equivalent approvals through affiliated companies in China and India, in exchange for manufacturing rights when the drugs are approved by Health Canada.

This has been quarterbacked by CEO Arun Nayyar, who has an extensive track record in the generics industry, having held executive positions with pharma companies in Latin America, Asia, and Canada and has played an instrumental role opening up new markets abroad

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist